Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2015

The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015;163(4):1011-25.

Rodrigues LU, Rider L, Nieto C, Romero L, Karimpour-Fard A, Loda M, et al. Coordinate loss of MAP3K7 and CHD1 promotes aggressive prostate cancer. Cancer Res. 2015;75(6):1021-34.

Mathieu R, Klatte T, Margulis V, Karam JA, Rouprêt M, Seitz C, et al. Survivin is not an independent prognostic factor for patients with upper tract urothelial carcinoma: a multi-institutional study. Urol Oncol. 2015;33(11):495.e15-22.

Millard AD, Westblade LF, LiPuma JJ, Vavikolanu K, Read TD, Pallen MJ, et al. Draft Genome Sequence of the Pandoraea apista LMG 16407 Type Strain. Genome Announc. 2015;3(6).

Piva R, Deaglio S, Famà R, Buonincontri R, Scarfò I, Bruscaggin A, et al. The Krüppel-like factor 2 transcription factor gene is recurrently mutated in splenic marginal zone lymphoma. Leukemia. 2015;29(2):503-7.

Isella C, Terrasi A, Bellomo SE, Petti C, Galatola G, Muratore A, et al. Stromal contribution to the colorectal cancer transcriptome. Nat Genet. 2015;47(4):312-9.

Nowak DG, Cho H, Herzka T, Watrud K, DeMarco DV, M Y Wang V, et al. MYC Drives Pten/Trp53-Deficient Proliferation and Metastasis due to IL6 Secretion and AKT Suppression via PHLPP2. Cancer Discov. 2015;5(6):636-51.

Jerris RC, Williams SR, MacDonald HJ, Ingebrigtsen DR, Westblade LF, Rogers BB. Testing implications of varying targets for Bordetella pertussis: comparison of the FilmArray Respiratory Panel and the Focus B. pertussis PCR assay. J Clin Pathol. 2015;68(5):394-6.

Chen EJ, Sowalsky AG, Gao S, Cai C, Voznesensky O, Schaefer R, et al. Abiraterone treatment in castration-resistant prostate cancer selects for progesterone responsive mutant androgen receptors. Clin Cancer Res. 2015;21(6):1273-80.

Srivatana V, Muthukumar T, Lee JB, Seshan SV, Hartono C. Quiz Page August 2015: Leukemoid Reaction and Acute Kidney Injury Following Kidney Transplantation. Am J Kidney Dis. 2015;66(2):xx-xxiii.